Merck Millipore announces 2013 price hike
Merck Millipore has announced plans to increase what it charges for chemical and biopharmaceutical processing solutions, citing rising costs.
Archives for October 17, 2012
Samsung halts biosimilar rituximab trial on regulatory concerns
Reports suggest that Samsung Biologics has halted a trial of a biosimilar version of Roche and Biogen Idec's Rituxan (rituximab).